Pharmacology

Broschiert (KB)

The most up-to-date edition of the gold-standard handbook on the safe and effective prescribing of psychotropic agents Prescribing medications that treat mental illness is a challenging but essential component of clinical practice. Successful treatment outcomes require careful drug choice and dosage, and other considerations can also have an important impact on patient experiences and long-term care. In the newly revised fifteenth edition of The Maudsley Prescribing Guidelines in Psychiatry, you will find up-to-date and authoritative guidance on prescribing psychotropic medications to patients. It is an indispensable evidence-based handbook that will continue to serve a new generation of clinicians and trainees. The book includes analyses of all psychotropic drugs currently used in the United States, the United Kingdom, Canada, Australia, New Zealand, and Japan. It also contains detailed discussions of common and uncommon adverse effects, the ramifications of switching medications, special patient groups, and other clinically relevant subjects. A fully updated reference list closes out each section, as well. The Maudsley Prescribing Guidelines in Psychiatry is perfect for trainees seeking essential and accurate information on the rational, safe, and effective use of medications for patients with mental illness. Practising clinicians will also benefit from the included guidance on complex issues that might arise less frequently.

This book focuses on the strategies and methods for quality control of Chinese medicines used in prevention and treatment of diseases for thousands of years in China and East Asia. It explains various strategies and methods for quality markers discovery and herbal glycoanalysis, as well as practices for control of heavy metal and pesticide residues. Strategies to overcome the shortage of reference compounds for quality control of Chinese medicines are also provided. The book also introduces analytical techniques for different analytes in Chinese medicines with an emphasis on sample preparation in automation and high extraction efficiency methods, the key process affecting the time and accuracy of the techniques. It is of interest to quality control scientists in academia and industry working on Chinese medicines and/or herbal medicine and also pharmacists, pharmacologists, food chemists, and nutritionists who want to understand Chinese medicines.

This book provides an overview of the drug discovery process from natural sources such as plants and microbes. While technological advances have streamlined the drug discovery process, enhancing the throughput and success rates, the structural features of natural products remain the primary reference for small-molecule drug discovery.Focusing on the drug targets blocked/altered by natural/nature-inspired molecules, it covers how potential drug leads are screened and identified using appropriate assay systems, and the current status of drugs identified using such approaches. State-of-the-art approaches in target identification, assay development, and lead identification have also been discussed in detail. Other topics included are targets and leads in inflammation, cancer, reproductive medicine, cardiovascular and neuromuscular ailments, and infectious diseases as well as the challenges in translating drug leads into clinically viable drugs.This volume serves as a handbook for researchers in phytochemistry and drug discovery, and as a reference for researchers and students of applied biology.

This book addressed an in-depth comprehension of the classifications and characterizations of POPs, which have become global issues due to bioaccumulation, persistency, and toxicity. It represents the milestones of the development of pesticide application, industry, and management. Banned SC-POPs have special investigations. It discusses air-sea exchange, ocean currents, phase distribution, speciation, adsorption, desorption, and degradation as the key processes that control POP's fate. The book explores several aspects of POP chemistry that have a direct influence on their biochemical and toxicological consequences. The book illustrates the dynamic equilibriums influencing the proportion of a POP's gaseous, liquid, and solid phases. The book discussed POP migration by referring to the grasshopper effect. It also explores the impacts of climate change on emissions and the fate of POPs through a global-scale multimedia fate model. Additionally, it displays the impact of potential global change scenarios on POP bioaccumulation patterns. The book is directed at giving a deep discussion of the method's QA/QC process for POP determination and has verified the accuracy and precision of the procedures. As a distinctive point, it discusses many aspects concerning the toxicity of POPs. It reports mechanisms describing the toxicity of POPs on immune systems, carcinogenesis, endocrine, neural, and reproductive systems. The book keeps an eye on a model describing the global distribution and toxicity of PAHs. Among the exclusive points in the book is the evaluation of the recent ecological status in Egypt relative to POPs through a time-scale overview and recent case studies. It provides thematic literature related to DDC research in Africa through the WoS and Scopus databases from 1949 to 2021. The book emphasizes models for predicting the annual contribution rate of POPs as a way to raise public awareness about POPs. The greatest challenge for the book is how to motivate the audience to be aware of these hazardous materials in marine ecosystems. Moreover, this book will be of great interest to academics, professionals, practitioners, post-graduate students, and undergraduates because it gives a clear overview of POPs in the marine environment. It also provides decision-makers with a realistic perspective of the environmental file, allowing them to address environmental issues and directing stockholders to safer locations for environmental activity. From a future perspective, the regulation of pervasive POPs, with special reference to recently evaluated harmful substances (PFASs), has faced significant challenges in the wake of pressure from regulators.

Biomimetic polymers and materials have been widely used in a variety of biomedical and pharmacological applications. Particularly, collagen-based biomaterials have been extensively applied in various biomedical fields, such as scaffolds in tissue engineering. However, there are many challenges associated with the use of mammalian collagen, including the issues of religious constrains, allergic or autoimmune reactions, and the spread of animal diseases. Over the past few decades, marine collagen (MC) has emerged as a promising biomaterial for biomedical and pharmacological applications. Marine organisms are a rich source of structurally novel and biologically active compounds, and to date, many biological components have been isolated from various marine resources. MC offers advantages over mammalian collagen due to its water solubility, low immunogenicity, safety, biocompatibility, antimicrobial activity, functionality, and low production costs. Due to its characteristics and physicobiochemical properties, it has tremendous potential for use as a scaffold biomaterial in tissue engineering and regenerative medicine, in drug delivery systems, and as a therapeutic.In this Special Issue, we encourage submissions related to the recent developments, advancements, trends, challenges, and future perspectives in this new research field. We expect to receive contributions from different areas of multidisciplinary research, including-but not restricted to-extraction, purification, characterization, fabrication, and experimentation of MC, with a particular focus on their biotechnological, biomedical and pharmacological uses.

The societal consequences of antimicrobial resistance (AMR) are severe. They include declining health outcomes from longer illnesses, prolonged stays in hospital, loss of protection for patients undergoing medical procedures, increased health care expenditure, and increased mortality. They also include declining global food security as AMR damages farm animal health and crop yields. Despite AMR being a transboundary crisis, concerted global initiatives that effectively combat AMR have been few and far between.Steering Against Superbugs analyses ways to reduce barriers and create opportunities for coordination. The expert contributions in this volume offer specific and original insights about what global governance of AMR means, and ways to help solve AMR issues. They show that effective governance relies crucially on pursuing local level implementation of key policies, and equitable recognition of solutions across multiple sectors within countries, and across the Global North and South. With the COVID-19 pandemic, societies across the world have been reminded of the devastating consequences of not being able to effectively counter global health threats. AMR is arguably one of the most severe long-term threats to human, animal, and environmental health. There is momentum for global political action around novel and emerging disease threats and Steering Against Superbugs contributes with original and insightful research to inform ongoing and future debates.